Device
Arctic Sun®
Arctic Sun® is a medical device with 5 clinical trials. Historical success rate of 50.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
1(20%)
Phase Distribution
Ph not_applicable
3
60%
Ph phase_2
2
40%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
N/ANon-phased studies
3(60.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(1)
Terminated(1)
Other(3)
Detailed Status
unknown3
Completed1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
50.0%
Most Advanced
Phase 2
Trials by Phase
Phase 22 (40.0%)
N/A3 (60.0%)
Trials by Status
completed120%
terminated120%
unknown360%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
Efficacy of Blanketrol III and Arctic Sun in Cooling Non-shivering Humans
NCT04332224
unknownnot_applicable
Comparison of Cerebral SctO2 Between 36℃ and 33℃ of TTM After Cardiac Arrest
NCT02889744
unknownphase_2
Mild Hypothermia After Endovascular Treatment in Acute Ischemic Stroke
NCT02985060
unknownnot_applicable
Targeted Temperature Management After In-Hospital Cardiac Arrest
NCT02578823
terminatedphase_2
Mild Hypothermia and Supplemental Magnesium Sulfate Infusion in Severe Traumatic Brain Injury (TBI) Subjects
NCT01333488
Clinical Trials (5)
Showing 5 of 5 trials
NCT04332224Not Applicable
Efficacy of Blanketrol III and Arctic Sun in Cooling Non-shivering Humans
NCT02889744Not Applicable
Comparison of Cerebral SctO2 Between 36℃ and 33℃ of TTM After Cardiac Arrest
NCT02985060Phase 2
Mild Hypothermia After Endovascular Treatment in Acute Ischemic Stroke
NCT02578823Not Applicable
Targeted Temperature Management After In-Hospital Cardiac Arrest
NCT01333488Phase 2
Mild Hypothermia and Supplemental Magnesium Sulfate Infusion in Severe Traumatic Brain Injury (TBI) Subjects
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5